SCHEMBL20104589

SCHEMBL20104589

CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCCC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC1R Q01726 7/20 0.53
MC4R P32245 6/20 0.53
MC5R P33032 6/20 0.53
PCSK9 Q8NBP7 1/20 0.52
MC3R P41968 5/20 0.52
KLKB1 P03952 1/20 0.52
HDAC3 O15379 1/20 0.52
HDAC4 P56524 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC10 Q969S8 1/20 0.52
HDAC11 Q96DB2 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
HDAC9 Q9UKV0 1/20 0.52
HDAC5 Q9UQL6 1/20 0.52
TUBB4A P04350 2/20 0.51
TUBB P07437 2/20 0.51
TUBA3C P0DPH7 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20104573 0.99 TUBB4A (0.52) MC1RMC4RMC5RPCSK9MC3R
SCHEMBL20104572 0.98 PCSK9 (0.52) MC1RMC4RMC5RPCSK9MC3R
SCHEMBL20104643 0.94 PCSK9 (0.59) MC1RMC4RMC5RPCSK9MC3R
SCHEMBL20104592 0.93 PCSK9 (0.58) MC1RMC4RMC5RPCSK9MC3R
SCHEMBL20104593 0.93 PCSK9 (0.58) MC1RMC4RMC5RPCSK9MC3R
SCHEMBL20104590 0.90 SSTR1 (0.58) MC1RMC4RMC5RPCSK9MC3R
SCHEMBL20100614 0.87 MC4R (0.57) MC1RMC4RMC5RPCSK9MC3R
SCHEMBL20104581 0.84 PCSK9 (0.62) MC1RMC4RMC5RPCSK9MC3R
SCHEMBL20104588 0.83 PCSK9 (0.62) MC1RMC4RMC5RPCSK9MC3R
SCHEMBL20100616 0.81 KLKB1 (0.59) MC1RMC4RMC5RPCSK9MC3R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11124541-B2 Chimeric melanocortin ligands and methods of use thereof REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2021-09-21 US disclosed
US-20180118789-A1 CHIMERIC MELANOCORTIN LIGANDS AND METHODS OF USE THEREOF REGENTS OF THE UNIVERSITY OF MINNESOTA 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11124541-B2 Chimeric melanocortin ligands and methods of use thereof MC3R, MC4R, MC1R MC1R 3/4885MC4R 2/4885MC5R 4/4885
US-20180118789-A1 CHIMERIC MELANOCORTIN LIGANDS AND METHODS OF USE THEREOF MC3R, MC4R, MC1R MC1R 3/4885MC4R 2/4885MC5R 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.